Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 33% ± 12% | |
brain | 12 studies | 25% ± 9% | |
peripheral blood | 8 studies | 24% ± 7% | |
kidney | 7 studies | 20% ± 3% | |
intestine | 7 studies | 21% ± 10% | |
eye | 7 studies | 36% ± 14% | |
heart | 5 studies | 19% ± 2% | |
liver | 5 studies | 37% ± 18% | |
placenta | 4 studies | 23% ± 7% | |
breast | 4 studies | 18% ± 1% | |
adipose | 4 studies | 26% ± 8% | |
pancreas | 3 studies | 32% ± 6% | |
skin | 3 studies | 20% ± 3% | |
lymph node | 3 studies | 17% ± 2% | |
prostate | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3100.09 | 1445 / 1445 | 100% | 30.69 | 183 / 183 |
ovary | 100% | 2598.66 | 180 / 180 | 100% | 35.14 | 430 / 430 |
prostate | 100% | 3001.79 | 245 / 245 | 100% | 43.28 | 502 / 502 |
breast | 100% | 3651.26 | 459 / 459 | 100% | 60.78 | 1117 / 1118 |
thymus | 100% | 4169.96 | 653 / 653 | 100% | 66.52 | 604 / 605 |
lung | 100% | 3299.54 | 577 / 578 | 100% | 45.97 | 1155 / 1155 |
bladder | 100% | 2839.57 | 21 / 21 | 100% | 38.12 | 503 / 504 |
brain | 100% | 2224.05 | 2635 / 2642 | 100% | 47.28 | 704 / 705 |
uterus | 100% | 3404.48 | 170 / 170 | 100% | 44.67 | 457 / 459 |
kidney | 100% | 3186.10 | 89 / 89 | 99% | 36.32 | 896 / 901 |
intestine | 100% | 3428.19 | 966 / 966 | 99% | 35.82 | 524 / 527 |
stomach | 100% | 2445.70 | 359 / 359 | 99% | 31.24 | 284 / 286 |
liver | 100% | 3334.96 | 226 / 226 | 99% | 35.00 | 403 / 406 |
pancreas | 99% | 1329.37 | 326 / 328 | 99% | 41.66 | 176 / 178 |
adrenal gland | 100% | 4434.60 | 258 / 258 | 97% | 39.84 | 224 / 230 |
skin | 100% | 2954.01 | 1809 / 1809 | 97% | 46.81 | 458 / 472 |
adipose | 100% | 3728.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 52.23 | 29 / 29 |
muscle | 100% | 4482.81 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3852.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.44 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.36 | 1 / 1 |
blood vessel | 100% | 3443.81 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2412.75 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 2440.74 | 880 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 22.19 | 72 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0006625 | Biological process | protein targeting to peroxisome |
GO_0015031 | Biological process | protein transport |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0005575 | Cellular component | cellular_component |
GO_0005829 | Cellular component | cytosol |
GO_0003677 | Molecular function | DNA binding |
GO_0031593 | Molecular function | polyubiquitin modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | ZFAND6 |
Protein name | AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3) Zinc finger AN1-type containing 6 AN1-type zinc finger protein 6 (Zinc finger A20 domain-containing protein 3) |
Synonyms | HT032 AWP1 ZA20D3 |
Description | FUNCTION: Involved in regulation of TNF-alpha induced NF-kappa-B activation and apoptosis. Involved in modulation of 'Lys-48'-linked polyubiquitination status of TRAF2 and decreases association of TRAF2 with RIPK1. Required for PTS1 target sequence-dependent protein import into peroxisomes and PEX5 stability; may cooperate with PEX6. In vitro involved in PEX5 export from the cytosol to peroxisomes (By similarity). . |
Accessions | ENST00000560228.5 ENST00000558087.5 [Q6FIF0-1] H0YME2 H3BMJ5 ENST00000558997.5 Q6FIF0 H3BPX9 ENST00000561060.5 [Q6FIF0-1] ENST00000261749.11 [Q6FIF0-1] ENST00000560392.5 ENST00000561012.5 ENST00000560470.5 ENST00000558390.5 H0YLR2 H3BM82 ENST00000564367.5 ENST00000558272.5 ENST00000559775.5 [Q6FIF0-1] ENST00000560976.5 ENST00000558688.5 H0YMG0 ENST00000613266.4 [Q6FIF0-1] ENST00000559835.5 [Q6FIF0-1] H3BP46 H0YMR5 ENST00000558494.5 [Q6FIF0-1] ENST00000616533.4 [Q6FIF0-1] ENST00000618205.4 [Q6FIF0-1] H0YK54 ENST00000558724.1 H3BT16 H0YK21 ENST00000559157.5 [Q6FIF0-2] |